⏱ 10 min read
Dr. Hayes Q&A · No. 019
By Eleanor Hayes, M.D. · Hospitalist
The Question
“At my checkup they asked if I wanted to add a PSA test. They said it screens for prostate cancer. I have no symptoms at all. Do I actually need this test? Isn’t getting it always the safer choice?”
— Name withheld
| The Basics | |
|---|---|
| Sex / Age | Male · 58 |
| Height / Weight | 5’9″ (175 cm) · 183 lb (83 kg) |
| Existing conditions | None |
| Family history | Father had prostate cancer in his 70s |
| Symptoms | None |
| Smoking | Former smoker, quit 10 years ago |
The Short Answer
A PSA test prostate cancer screening is not a test you always say yes to. For men aged 55 to 69, whether to get it is a personal decision made together with your physician, after you understand both the benefits and the harms. Getting it can be the right call, and so can skipping it. There is no default answer that fits everyone.
Why a PSA Test Prostate Cancer Screening Isn’t Automatic
PSA stands for prostate-specific antigen, a protein made by the prostate. It can rise with prostate cancer, which is why it is used for screening. But it also rises with an enlarged prostate, with inflammation, and simply with age. It is specific to the prostate, not to cancer. That single fact is the root of everything that makes this decision complicated.
The current guidance reflects that. The U.S. Preventive Services Task Force recommends that men aged 55 to 69 make an individual decision about PSA screening after discussing the benefits and harms with their clinician, a shared decision. For men 70 and older without symptoms, it recommends against routine screening. The Centers for Disease Control and Prevention frames it the same way: men 55 to 69 should decide individually, and men 70 and older should not be screened routinely.
The Benefit and the Harm, Side by Side
Both are real, and holding them together is the whole point.
On the benefit side, screening men aged 55 to 69 may prevent about 1.3 prostate cancer deaths over roughly 13 years for every 1,000 men screened. That is a real life saved, and it is not nothing.
On the harm side sit false positives, overdiagnosis, and what follows them. A raised PSA can lead to a biopsy, and a biopsy can find a slow cancer that would never have caused trouble in a man’s lifetime. Treating that cancer carries its own risks, including incontinence and erectile dysfunction. So the harm is not only anxiety. It is the chance of being treated for something that was never going to hurt you.
| Possible Benefit | Possible Harm | |
|---|---|---|
| What it does | Can catch treatable, higher-risk cancer early | False positives and overdiagnosis |
| What follows | Treatment while a cure is likely | Biopsy and treatment you may not have needed |
| The scale | ~1.3 deaths prevented per 1,000 over 13 years | Many detected cancers never needed treatment |
Where Your Own Values Tip the Scale
This is where this reader’s details matter. The Task Force specifically identifies Black men and men with a family history of prostate cancer as being at higher risk. A father who had prostate cancer is exactly the kind of fact that can shift the balance toward screening for a given man.
That is what “shared decision” really means. It is not a polite phrase for “do whatever you want.” It means the same test can be a reasonable yes for one man and a reasonable no for another, and the deciding factor is often the personal history he brings to the conversation. A family history like this reader’s is a genuine reason to lean in and talk it through, not a reason to skip the discussion.
It helps to know why the guidance itself softened. In 2012 the Task Force recommended against PSA screening for all men. By 2018 it had moved to shared decision-making for the 55-to-69 group, in part because the rise of active surveillance, watching a low-risk cancer rather than rushing to treat it, reduced some of the harm that treatment used to guarantee.
Plain-Language Reference
| Term | What It Means in Plain Language |
|---|---|
| PSA | A prostate protein that can rise with cancer, but also with many harmless things. |
| Shared decision-making | You and your doctor weigh benefits and harms and decide together. |
| False positive | A worrying result when no dangerous cancer is present. |
| Overdiagnosis | Finding a cancer that never would have caused harm. |
| Active surveillance | Closely watching a low-risk cancer instead of treating it right away. |
What I See in the Hospital
The belief I meet most often is that more testing is always better. With screening, that is not how it works. Not everything a test finds needs treating, and some findings lead straight to anxiety and to procedures that carry real risk. A PSA is one of those tests you decide about before you draw the blood, not after.
The value of a screening test depends on the test and the person, never on the assumption that doing more is doing better. That is the same lesson that runs through every honest conversation about screening.
What to Actually Do
· Do not treat a PSA as an automatic yes. If you are 55 to 69, weigh the benefits and harms with your physician and decide together.
· If you have a family history or are at higher risk, say so, and let it count in the decision. A father with prostate cancer is an important part of that conversation.
· If you are 70 or older with no symptoms, know that the guidance advises against routine screening.
· If a result comes back high, do not rush straight to biopsy or treatment. Talk through the next step calmly with your physician.
More From Dr. Hayes Q&A
Other reader questions that connect to this one:
· Q&A 011: My labs are normal but I feel terrible (what a normal range really means)
· Q&A 017: What a high CRP inflammation blood test means (another number that is not a diagnosis on its own)
This article is for general information only and does not constitute medical advice, and reading it creates no provider-patient relationship. Whether to undergo PSA screening is a decision that depends on your individual risk, values, and health, and it should be made together with a licensed clinician who knows your history. This article does not recommend for or against screening for any individual. Importantly, screening is for people without symptoms. If you have urinary difficulty, blood in the urine, bone pain, or other symptoms, that is not a screening question but a reason to see a physician promptly for evaluation.
Take care of yourself. Nobody else will do it for you.
— Eleanor Hayes, M.D.
Eleanor Hayes, M.D., is a practicing, board-certified Family Medicine physician with extensive hospital-based clinical experience across multiple U.S. regions. At ManClub she writes data-driven pieces on public health, healthcare systems, and population health trends, and serves as the site’s independent medical reviewer. “Eleanor Hayes” is a professional pen name used to protect patient privacy; all credentials are verified internally. She is the author of “Reading the Table” (2026). Full bio and credentials: Dr.Hayes-reviewer. Contact: [email protected].